Addiction potential of cigarettes with reduced nicotine content in populations with psychiatric disorders and other vulnerabilities to tobacco addiction

JAMA Psychiatry

Volumn 74, Issue 10, 2017, Pages 1056-1064

  Higgins, Stephen T ^a   Heil, Sarah H ^a   Sigmon, Stacey C ^a   Tidey, Jennifer W ^b   Gaalema, Diann E ^a   Hughes, John R ^a   Stitzer, Maxine L ^c   Durand, Hanna ^a   Bunn, Janice Y ^a   Priest, Jeff S ^a   Arger, Christopher A ^a   Miller, Mollie E ^b   Bergeria, Cecilia L ^a   Davis, Danielle R ^a   Streck, Joanna M ^a   Reed, Derek D ^d   Skelly, Joan M ^a   Tursi, Lauren ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b BROWN UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BEHAVIOR ASSESSMENT; CIGARETTE EVALUATION QUESTIONNAIRE; CIGARETTE PURCHASE TASK; CLINICAL ASSESSMENT; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINNESOTA NICOTINE WITHDRAWAL SCALE; MOOD DISORDER; MULTICENTER STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; QUESTIONNAIRE; QUESTIONNAIRE OF SMOKING URGES BRIEF SCALE; SMOKING; SMOKING CESSATION; SOCIAL STATUS; SOCIOECONOMICS; TOBACCO DEPENDENCE; VULNERABLE POPULATION; WITHDRAWAL SYNDROME; ADDICTION; ANALYSIS; CONTROLLED STUDY; PREVENTION AND CONTROL; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TOBACCO; TOBACCO USE DISORDER;

ADULT; BEHAVIOR, ADDICTIVE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NICOTINE; OUTCOME ASSESSMENT (HEALTH CARE); SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 85030646296     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2017.2355     Document Type: Article

References (41)

1. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
2. Schroeder SA. American health improvement depends upon addressing class disparities. Prev Med. 2016;92:6-15. doi:10.1016/j.ypmed.2016.02.024
3. Higgins ST. Editorial: 3rd special issue on behavior change, health, and health disparities. Prev Med. 2016;92:1-5. doi:10.1016/j.ypmed.2016.09.029
4. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.1001/jama.284.20.2606
5. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248:107-123. doi:10.1111/j.1749-6632.2011.06202.x
6. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503-508. doi:10.1001/archpsyc.58.5.503
7. Family Smoking Prevention and Tobacco Control Act. HR 1256. 111th Congress (2009-2011).
8. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction: the implications for tobacco regulation. N Engl J Med. 1994;331(2): 123-125. doi:10.1056/NEJM199407143310212
9. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343-355. doi:10.1111/j.1360-0443.2009.02780.x
10. Hatsukami DK, Hertsgaard LA, Vogel RI, et al. Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev. 2013;22 (6):1015-1024. doi:10.1158/1055-9965.EPI-12-1439
11. Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2012;21(5):761-769. doi:10.1158/1055-9965.EPI-11-0644
12. Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340-1349. doi:10.1056/NEJMsa1502403
13. Kozlowski LT, O’Connor RJ, Sweeney CT. Cigarette design. In: Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2001:13-37. Smoking and Tobacco Control monograph No. 13.
14. Higgins ST, Chilcoat HD. Women and smoking: an interdisciplinary examination of socioeconomic influences. Drug Alcohol Depend. 2009;104(suppl 1):S1-S5. doi:10.1016/j.drugalcdep.2009.06.006
15. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285. doi:10.1186/1471-2458-9-285
16. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ. 2015;351:h4065. doi:10.1136/bmj.h4065
17. Substance Abuse and Mental Health Services Administration. Results from the 2015 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2016. https://datafiles.samhsa.gov/study/national-survey-drug-use-and-health -nsduh-2015-nid16893. Accessed May 4, 2017.
18. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2013;15(1):121-129. doi:10.1093/ntr/nts098
19. AhnAllen CG, Bidwell LC, Tidey JW. Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls. Nicotine Tob Res. 2015;17(5):510-514. doi:10.1093/ntr/ntu163
20. Tidey JW, Cassidy RN, Miller ME. Smoking topography characteristics of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls. Nicotine Tob Res. 2016;18(9):1807-1812. doi:10.1093/ntr/ntw089
21. Higgins ST, Heil SH, Sigmon SC, et al. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology (Berl). 2017;234(1):89-98. doi:10.1007/s00213-016-4438-z
22. Tidey JW, Pacek LR, Koopmeiners JS, et al. Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms. Nicotine Tob Res. 2017;19(1): 59-67.
23. Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res. 2003;5(5):673-679. doi:10.1080/1462220031000158645
24. Jacobs EA, Bickel WK. Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients. Exp Clin Psychopharmacol. 1999;7(4):412-426. doi:10.1037/1064-1297.7.4.412
25. MacKillop J, Murphy JG, Ray LA, et al. Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Exp Clin Psychopharmacol. 2008; 16(1):57-65. doi:10.1037/1064-1297.16.1.57
26. Wilson AG, Franck CT, Koffarnus MN, Bickel WK. Behavioral economics of cigarette purchase tasks: within-subject comparison of real, potentially real, and hypothetical cigarettes. Nicotine Tob Res. 2016;18(5):524-530. doi:10.1093/ntr/ntv154
27. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified Cigarette Evaluation Questionnaire. Addict Behav. 2007;32 (5):912-923. doi:10.1016/j.addbeh.2006.06.028
28. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986; 43(3):289-294. doi:10.1001/archpsyc.1986.01800030107013
29. Cox LS, Tiffany ST, Christen AG. Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7-16. doi:10.1080/14622200020032051
30. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9): 1119-1127.
31. Lussier JP, Higgins ST, Badger GJ. Influence of the duration of abstinence on the relative reinforcing effects of cigarette smoking. Psychopharmacology (Berl). 2005;181(3):486-495. doi:10.1007/s00213-005-0008-5
32. Johnson MW, Bickel WK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes. Drug Alcohol Depend. 2004;74(3):253-264. doi:10.1016 /j.drugalcdep.2003.12.012
33. Sigmon SC, Tidey JW, Badger GJ, Higgins ST. Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology (Berl). 2003;167(4):393-402. doi:10.1007/s00213-003-1416-z
34. Koffarnus MN, Franck CT, Stein JS, Bickel WK. A modified exponential behavioral economic demand model to better describe consumption data. Exp Clin Psychopharmacol. 2015;23(6):504-512. doi:10.1037/pha0000045
35. Stein JS, Koffarnus MN, Snider SE, Quisenberry AJ, Bickel WK. Identification and management of nonsystematic purchase task data: toward best practice. Exp Clin Psychopharmacol. 2015;23(5): 377-386. doi:10.1037/pha0000020
36. Smith TT, Cassidy RN, Tidey JW, et al. Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial. Addiction. 2017;112(2):349-359. doi:10.1111/add.13636
37. Bickel WK, DeGrandpre RJ, Hughes JR, Higgins ST. Behavioral economics of drug self-administration, II: a unit-price analysis of cigarette smoking. J Exp Anal Behav. 1991;55(2): 145-154. doi:10.1901/jeab.1991.55-145
38. Smith TT, Sved AF, Hatsukami DK, Donny EC. Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach. Prev Med. 2014;68:23-28. doi:10.1016/j.ypmed.2014.07.005
39. Griffiths RR, Bigelow GE, Ator NA. Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend. 2003;70(3) (suppl):S41-S54. doi:10.1016/S0376-8716(03) 00098-X
40. Balster RL, Bigelow GE. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend. 2003;70 (3)(suppl):S13-S40. doi:10.1016/S0376-8716(03)00097-8
41. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob Res. 1999;1 (4):357-364. doi:10.1080/14622299050011491